ArticleTargeted oncology2016

Ongoing Response in BRAF V600E-Mutant Melanoma After Cessation of Intermittent Vemurafenib Therapy: A Case Report.

Andrew J Dooley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.